Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Key facts

Sponsor

Eastern Cooperative Oncology Group

Principal Investigator

Dong M. Shin, MD, MD

Emory University

Intervention

recombinant interferon alfa(biological)

Eligibility

18-120 years · All sexes

Timeline

2003 – 2009

Study locations (30)

• University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
• CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
• City of Hope Comprehensive Cancer Center, Duarte, California, United States
• Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States
• Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
• CCOP - Christiana Care Health Services, Newark, Delaware, United States
• MBCCOP - Howard University Cancer Center, Washington D.C., District of Columbia, United States
• Veterans Affairs Medical Center - Gainesville, Gainesville, Florida, United States
• Veterans Affairs Medical Center - Miami, Miami, Florida, United States
• H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
• Veterans Affairs Medical Center - Tampa (Haley), Tampa, Florida, United States
• Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
• Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States
• Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States
• Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07195734
  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  National Cancer Institute (NCI)
• RECRUITINGNANCT07264036
  Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
  Vanessa Torrecillas
• RECRUITINGPHASE2NCT07121595
  Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
  University of Michigan Rogel Cancer Center
• RECRUITINGNCT05837221
  Microbiome in Head and Neck Squamous Cell Carcinoma
  University of Colorado, Denver
• RECRUITINGPHASE2NCT05576974
  A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
  University of Texas Southwestern Medical Center
• RECRUITINGPHASE1, PHASE2NCT06265025
  GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
  GeneMedicine Co., Ltd.
• RECRUITINGNANCT05811936
  The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
  Medical University of South Carolina
• ACTIVE NOT RECRUITINGPHASE1NCT05820711
  Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
  University of Wisconsin, Madison

See all trials for Squamous cell carcinoma of oral cavity and lip →